Dermatology Devices Industry is Boosted by the Increasing Prevalence of Skin Diseases

The total size of the dermatology devices market was USD 7,117.4 million in 2023, and it will grow at a compound annual growth rate of 12.9% by the end of this decade, to touch a value of USD 16,552.7 million by 2030. 

This is because of the growing incidence of skin ailments all over the world, rising consciousness of aesthetic procedures, mounting healthcare spending in emerging nations, and dermatology devices letting dermatologists and surgeons to identify and treat numerous skin ailments in time.

There is a notable surge in the incidence of skin ailments at a global level recently, particularly amongst people living in regions with higher ozone exhaustion. The most common conditions are eczema, acne vulgarism, urticaria, sunburn, herpes zoster, and rosacea, contributing to the increasing acceptance of dermatology devices.

The imaging devices category will grow at a rate of 13.3% in the years to come. This is because of the growing requirement for diagnostic devices as a result of the increasing incidence of various skin disorders and skin cancer.

In 2023, North America led the industry with a share, of 55%, in the industry. This is because of the increasing incidence of skin ailments, the growing consciousness with regards to aesthetic cosmetic surgeries, the existence of leading players, the growing healthcare spending of the government, and easy availability of cutting-edge technologies.

Furthermore, in the U.S., over the past half a decade, about 7,000 novel incidences of self-reported skin issues have taken place every year. Amongst these, roughly 53% of contact dermatitis cases were sensitized, and 60% were as a result of irritants. Consequently, the acceptance of cutting-edge dermatology diagnostics is on the rise, and, in turn, is boosting the industry development in the nation.

It is because of the rising prevalence of skin diseases all over the world, the demand for dermatology devices is on the rise. And, this trend will continue in the years to come as well.

Read More

North America Is Dominating Dental Contouring Industry

The value of the dental contouring market stood at USD 2,848.3 million in 2023, and this number is projected to reach USD 4,283.7 million by 2030, advancing at a CAGR of 6.1% during the projection period. 

This development of the market can be credited to the increasing awareness of aesthetics and the growing demand for high-accuracy equipment for numerous teeth and gum treatment. Because of the tooth problems, people become unconfident about their smiles. The dental contouring process helps in advancing the symmetry of the teeth and eases their overlapping, by decreasing the amount of enamel existing on them, so they appear good.

In 2023, Diamond burs held the largest share, of 35%, this can be credited to their extreme hardness, due to this they can even grind enamel and allow faster and smoother cutting. Such devices are utilized when a high level of accuracy is needed during placing and shaping crowns, cutting via zirconia, and grinding porcelain.

The North American region has the dominating place in the dental contouring industry, and it will grip the same position during the projection period, with a value of USD 1.2 billion, credited to the fast acceptance of new and cutting-edge technologies in the continent. 

Furthermore, the increasing acceptance of such instruments and procedures, with the high expenditure power of people, is projected to fuel the industry in the continent. Also, the major players are concentrating on the growth of new items, acquisitions, mergers and collaborations, to attain a better position and greater consumer base.

Read More

Allergy Diagnostics Market is Led by North America

The allergy diagnostics market is estimated to reach USD 6,103.3 million in 2023, which will touch USD 12,814.2 million, with an 11.2% compound annual growth rate, by 2030.

The growth of this industry is because of the rising levels of environmental pollution, increasing investment to enhance allergy diagnostics by private & public administrations, and the occurrence of allergic disorders.

Furthermore, the inactive lifestyles, characterized by smoking, consumption of alcohol, and poor food habits; coupled with the high demand for in-vitro blood testing will further boost the industry expansion.

The consumables category, based on offering, is leading the industry in 2023, with a 45% share. This can be because consumables are an important component in detecting allergies.

North America is leading the industry in 2023, with a 55% share. This can be because of the strong healthcare system, swift technological developments in the medical sector, and advantageous reimbursement rules.

Additionally, the surging occurrence of allergies, coupled with the presence of inspiring procedures by associations to increase consciousness and make treatment and diagnosis available are also major contributors.

APAC will progress at the highest rate, of 11.5%, in the years to come. This can be primarily attributed to the requirement for less-invasive diagnostic technologies, speedily growing medical infrastructure, surging medical tourism activities, and unfulfilled clinical requirements.

With the rising levels of environmental pollution, the allergy diagnostics industry will continue to progress in the years to come.

Read More

Therapeutic Drug Monitoring Market Is Led by North America

The therapeutic drug monitoring market is estimated to generate USD 1,961.6 million in 2023, which will rise to USD 3,764.1 million, growing at a 9.8% compound annual growth rate, by 2030.

The growth of this industry is because of the rising need for genetic testing, developments in diagnostic technologies, enhancing healthcare infrastructure, and the mounting R&D expenses in healthcare.

Moreover, the industry is also boosted by the increasing product launches, the growing count of patients with chronic ailments, and the existence of helpful government regulatory guidelines and policies about the utilization of medication monitoring.

The immunoassays category, based on technology, is the largest contributor to the industry in 2023, with a 65% share, and it will remain the largest during this decade. This can be because of their high accessibility as well as rising usage in the discovery of medication analysis and development.

North America is leading the industry in 2023, with a 50% share, and it will remain leading throughout this decade. This can be because of the existence of key companies, along with the government auspicious rules that permit drug monitoring mainly in primary healthcare centers and private labs.

APAC is likely to propel at the fastest rate in the years to come. This is because of the large patient populace base, increasing customer expenditure, and rising per capita income in the region. 

The regional industry is also driven by the increasing economic advancement in APAC countries such as China, Japan, South Korea, and India.

With the surging need for genetic testing and enhancing healthcare infrastructure, the therapeutic drug monitoring industry will continue to progress in the coming years.

Read More

North America Is Dominating In-Situ Hybridization Industry

In 2023, the in-situ hybridization market amounted to USD 1,742.3 million and is set to grow at a compound annual growth rate of 12.8% between 2024 and 2030 reaching an estimated amount of USD 4,017.3 million by 2030.

This development of the market can be credited to the increasing acceptance of the in-situ hybridization (ISH) process for identifying numerous genetic illnesses and cancer, the rising pace of improvements in this method, and growing private and public funding for the research and development sector. Moreover, the rising demand for modified medicines is projected to fuel the industry growth.

There has been a distressing surge in cases of cancer worldwide in the past few years. This has caused a surge in the number of examined studies connected with this illness and those revolving around certain genomic irregularities, which are likely risk factors for numerous types of carcinomas.

In 2023, the FISH technology had a significant share, credited to the extensive variety of applications of this tech in diagnostics, like characterization with the aid of marker chromosomes, finding of numerical and structural chromosome flaws, finding of unusual and hereditary conditions, and drug abuse tracking.

In 2023, the North American region, generated the largest revenue share, of 55%, in the worldwide industry for in-situ hybridization solutions. The North American industry is projected to continue to uphold its dominating position during the projection period, mainly credited to the increasing count of autosomal diseases, cancer cases, genetic disorders, and also communicable conditions in the continent.

The U.S. is the key revenue generator in North America, mainly because of the strong government and private backing for the growth of new companion diagnostics methods.

Read More

Circuit Monitoring Market Will Touch USD 949.1 Million in 2030

The circuit monitoring market is estimated to generate USD 702.5 million in 2023, which will touch USD 949.1 million, propelling at a 4.5% compound annual growth rate, by 2030. 

The progression of this industry is because of the increasing need for data centers, coupled with the rising worries about energy stability & personnel safety. 

The modular circuit category, based on type, will be the larger contributor, with over 65% share, in 2023, and it is expected to continue this trend during this decade. This is because of the benefits it offers in monitoring modular circuits like easier connectivity and easy installation, while offering prompt access to information in a user-friendly way. 

Whereas, the branch & multi-circuit category will propel at a higher rate during this decade. This can be because of the enhancement in technology, coupled with the benefits provided by these circuits, such as a compact size, which is more space-saving than other monitoring systems. 

In addition, these circuits are widely employed at data centers, commercial & residential spaces, and manufacturing facilities because of their multi-point application. 

The commercial category, based on end user, will be the largest contributor to the circuit monitoring market, with a 35% share, in 2023, and it will remain the largest throughout this decade. This can be because of the surging count of data centers across the globe, along with their rising acceptance of circuit monitoring to determine energy usage and circuit effectiveness. 

The industrial category, on the other hand, is likely to propel at the fastest rate in the years to come. This will be because of the enhancing industrial infrastructure all over the world and the rising acceptance of circuit monitoring to continuously manage the current flow and avoid disruptions in production.

North America will be the largest contributor to the industry in 2023, with approximately 55%, and it will further progress at a robust rate during this decade. This continent is observing a significant increase in the count of data centers, which offer profitable opportunities to existing and new players in this industry to tap more customer base.

Read More

Transport Media Market is Driven by Increasing Occurrence of Infectious Diseases

The transport media market is estimated to reach USD 3,101.3 million in 2023, which will increase to USD 4,210.6 million, with a 4.6% compound annual growth rate, by 2030.

The growth of this industry is because of the rising R&D on viral illnesses, increasing need for pre-clinical and diagnostic testing, and the surging occurrence of infectious ailments like influenza and herpes.

For example, in 2022, around 400,000 individuals died from influenza globally. Likewise, approximately 4 billion individuals have herpes. Moreover, the growing count of government initiatives to enhance the acceptance of testing kits is also boosting the industry.

The viral transport media category, based on product type, is leading the industry, with a 35% share, in 2023. This can be because of the unexpected outbreak of infectious ailments like COVID-19 and monkeypox, which boost the requirement for testing and diagnosis among the infected people.

North America is dominating the industry. This is because of the surging number of diagnostic tests, rising R&D on infectious ailments, well-established healthcare system, and the existence of numerous pharma and biotech businesses.

Basically, the surging occurrence of infectious illnesses, particularly viral ailments, is a main factor that assists in revenue generation for industry players.

APAC will advance at the fastest compound annual growth rate during this decade, because of the rising prevalence of infectious illnesses like Lyme disease, tuberculosis, and COVID-19.

Moreover, the number of people with infectious illnesses is quite high in APAC, particularly in India and China. Therefore, several industry players have arrived to satisfy the vast unmet necessity for diagnosis.

It is because of the increasing research & development in viral ailments and the mounting incidence of infectious illnesses, the transport media industry will continue to progress in the coming years.

Read More